These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6419013)

  • 41. Genes of the major histocompatibility complex in mouse and man.
    Steinmetz M; Hood L
    Science; 1983 Nov; 222(4625):727-33. PubMed ID: 6356354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of immune response genes on the expression of disease.
    Stobo JD
    J Lab Clin Med; 1982 Dec; 100(6):822-8. PubMed ID: 6815287
    [No Abstract]   [Full Text] [Related]  

  • 43. Minor histocompatibility genes and their antigens.
    Graff RJ
    Transplant Proc; 1978 Dec; 10(4):701-5. PubMed ID: 104415
    [No Abstract]   [Full Text] [Related]  

  • 44. Localization of the human MHC-linked complement genes between HLA-B and HLA-DR by using HLA mutant cell lines.
    Whitehead AS; Colten HR; Chang CC; Demars R
    J Immunol; 1985 Jan; 134(1):641-3. PubMed ID: 3917284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resistance to murine 402AX teratocarcinoma: regulation by H-2IA and H-3 to H-13 region genes.
    Ostrand-Rosenberg S; McCarthy C
    Immunogenetics; 1984; 19(1):77-82. PubMed ID: 6693137
    [No Abstract]   [Full Text] [Related]  

  • 46. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.
    Collins T; Korman AJ; Wake CT; Boss JM; Kappes DJ; Fiers W; Ault KA; Gimbrone MA; Strominger JL; Pober JS
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4917-21. PubMed ID: 6431411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of the HLA-DR antigens incorporated into liposomes to generate HLA-DR specific cytotoxic T lymphocytes.
    Gorga JC; Foran J; Burakoff SJ; Strominger JL
    Methods Enzymol; 1984; 108():607-13. PubMed ID: 6335556
    [No Abstract]   [Full Text] [Related]  

  • 48. [Immunohistologic analysis of chronic obstructive sialadenitis. I. Changes in the expression of antigens of the major histocompatibility complex].
    Möller P; Born IA; Momburg F; Moldenhauer G; Maier H; Weidauer H; Otto HF
    Laryngol Rhinol Otol (Stuttg); 1986 Apr; 65(4):201-7. PubMed ID: 3520195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genes of the major histocompatibility complex.
    Hood L; Steinmetz M; Goodenow R; Eakle K; Fisher D; Kobori J; Malissen B; Malissen M; McMillan M; McNicholas J; Orn A; Pecht M; Sher BT; Smith L; Stroynowski I; Sun H; Winoto A; Zuniga M
    Cold Spring Harb Symp Quant Biol; 1983; 47 Pt 2():1051-65. PubMed ID: 6305572
    [No Abstract]   [Full Text] [Related]  

  • 50. An immunogenetic analysis Skn antigens in mice.
    Fleming HL; Silvers WK
    Immunogenetics; 1981 Dec; 14(6):517-26. PubMed ID: 7033121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients.
    Pachot A; Monneret G; Brion A; Venet F; Bohé J; Bienvenu J; Mougin B; Lepape A
    Crit Care Med; 2005 Jan; 33(1):31-8; discussion 236-7. PubMed ID: 15644645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of the class I genes of the mouse major histocompatibility complex by DNA-mediated gene transfer.
    Goodenow RS; McMillan M; Nicolson M; Sher BT; Eakle K; Davidson N; Hood L
    Nature; 1982 Nov; 300(5889):231-7. PubMed ID: 6815535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The phylogeny of mammalian histocompatibility immunogenes.
    Clark EA; Harmon RC
    Transplant Proc; 1979 Mar; 11(1):1113-7. PubMed ID: 313094
    [No Abstract]   [Full Text] [Related]  

  • 54. Specific control of responsiveness by two complementing Ir loci in the H-2 complex.
    Melchers I; Rajewsky K
    Eur J Immunol; 1975 Nov; 5(11):753-9. PubMed ID: 829899
    [No Abstract]   [Full Text] [Related]  

  • 55. The immunobiology of the T cell response to Mls-locus-disparate stimulator cells. I. Unidirectionality, new strain combinations, and the role of Ia antigens.
    Janeway CA; Katz ME
    J Immunol; 1985 Apr; 134(4):2057-63. PubMed ID: 2579125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DR alpha: E beta heterodimers in DRA transgenic mice hinder expression of E alpha: E beta molecules and are more efficient in antigen presentation.
    Trembleau S; Giacomini P; Guéry JC; Setini A; Hammer J; Sette A; Appella E; Adorini L
    Int Immunol; 1995 Dec; 7(12):1927-38. PubMed ID: 8746562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mouse hepatitis virus A59 increases steady-state levels of mRNAS encoding major histocompatibility complex antigens.
    Gombold JL; Weiss SR
    Adv Exp Med Biol; 1990; 276():593-9. PubMed ID: 1966454
    [No Abstract]   [Full Text] [Related]  

  • 58. The regulation of expression of major histocompatibility complex products.
    Halloran PF; Wadgymar A; Autenried P
    Transplantation; 1986 Apr; 41(4):413-20. PubMed ID: 2421465
    [No Abstract]   [Full Text] [Related]  

  • 59. The biological function of the major histocompatibility complex: hypotheses.
    Meruelo D; Edidin M
    Contemp Top Immunobiol; 1980; 9():231-53. PubMed ID: 6244914
    [No Abstract]   [Full Text] [Related]  

  • 60. The class II genes of the rat MHC.
    Diamond AG; Hood LE; Howard JC; Windle M; Winoto A
    J Immunol; 1989 May; 142(9):3268-74. PubMed ID: 2496165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.